OceanDocs >
Africa >
Kenya >
Kenya Marine and Fisheries Research Institute >
Other Reports >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1834/1291

Title: Novel Pharmaceuticals from Kenyan Marine Cyanobacteria
Authors: Dzeha, T.
ASFA Terms: Bacteria
Pharmaceutical products
Issue Date: 2004
Abstract: Two projects undertaken at the Heriot-Watt University, Edinburgh, U.K as part of the WIOMSA Marg II Programme are presented here. Project 1 was on studies carried out on the Kenyan marine cyanobacterium Lyngbya majuscula, which was collected from Shimoni, 100 km south of Mombasa, Kenya and ferried to the U.K on 12th October 2003. Specifically, L. majuscula was investigated on the potential for bioprocess intensified production of secondary metabolites with therapeutic potential, the Chemistry of its secondary metabolites and that of the cultures, and on the 16S rDNA classification of its epiphytic bacteria isolates. Project 2 focused on the isolation of cell-cell signaling inducer compounds from biofilms of marine bacteria Bacillus licheniformis EI-34-6.
Description: WIOMSA/MARG-II/2004/03
URI: http://hdl.handle.net/1834/1291
Related document: http://www.wiomsa.org/
Appears in Collections:Other Reports

Files in This Item:

File Description SizeFormat
WIOMSAMARG-II200403TDZEHA.pdf491.16 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.